Presence of intact vpu and nef genes in nonpathogenic SHIV is essential for acquisition of pathogenicity of this virus by serial passage in macaques

被引:20
作者
Mackay, GA
Niu, YF
Liu, ZC
Mukherjee, S
Li, Z
Adany, I
Buch, S
Zhuge, W
McClure, HM
Narayan, O
Smith, MS
机构
[1] Univ Kansas, Med Ctr, Dept Microbiol, Marion Merrell Dow Lab Viral Pathogenesis, Kansas City, KS 66160 USA
[2] Univ Kansas, Med Ctr, Dept Med, Div Infect Dis, Kansas City, KS 66160 USA
[3] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA
[4] Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30322 USA
关键词
SHIV; HIV; vaccine; nef; vpu; pathogenicity;
D O I
10.1006/viro.2002.1368
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Use of the macaque model of human immunodeficiency virus (HIV) pathogenesis has shown that the accessory genes nef and vpu are important in the pathogenicity of simian immunodeficiency virus (SIV) and simian-human immunodeficiency virus (SHIV). We examined the ability of two nonpathogenic SHIVs, SHIVPPC and DeltavpuDeltanefSHIV(PPC), to gain pathogenicity by rapid serial passage in macaques. In this study, each virus was passaged by blood intravenously four times at 4-week intervals in macaques. Animals were monitored for 40 weeks for levels of CD4 T cells and quantitative measures of virus infection. DeltavpuDeltanefSHIV(PPC) maintained a limited phase of productive replication in the four animals, with no loss of CD4(+) T cells, whereas SHIVPPC became more pathogenic in later passages, judging by plasma viral load and viral mRNA in lymph nodes, infectious peripheral blood mononuclear cells and CD4(+) T cell loss. The nef, LTR, and env of the SHIVPPC viruses underwent numerous mutations, compared to DeltavpuDeltanefSHIV(PPC). This study confirms the seminal role that nef, LTR, and vpu could play in regulation of pathogenesis of HIV infection. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:133 / 146
页数:14
相关论文
共 55 条
[1]   Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques [J].
Baba, TW ;
Liska, V ;
Khimani, AH ;
Ray, NB ;
Dailey, PJ ;
Penninck, D ;
Bronson, R ;
Greene, MF ;
McClure, HM ;
Martin, LN ;
Ruprecht, RM .
NATURE MEDICINE, 1999, 5 (02) :194-203
[2]   PATHOGENICITY OF LIVE, ATTENUATED SIV AFTER MUCOSAL INFECTION OF NEONATAL MACAQUES [J].
BABA, TW ;
JEONG, YS ;
PENNINCK, D ;
BRONSON, R ;
GREENE, MF ;
RUPRECHT, RM .
SCIENCE, 1995, 267 (5205) :1820-1825
[3]   Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination [J].
Barouch, DH ;
Santra, S ;
Schmitz, JE ;
Kuroda, MJ ;
Fu, TM ;
Wagner, W ;
Bilska, M ;
Craiu, A ;
Zheng, XX ;
Krivulka, GR ;
Beaudry, K ;
Lifton, MA ;
Nickerson, CE ;
Trigona, WL ;
Punt, K ;
Freed, DC ;
Guan, LM ;
Dubey, S ;
Casimiro, D ;
Simon, A ;
Davies, ME ;
Chastain, M ;
Strom, TB ;
Gelman, RS ;
Montefiori, DC ;
Lewis, MG ;
Emini, EA ;
Shiver, JW ;
Letvin, NL .
SCIENCE, 2000, 290 (5491) :486-492
[4]   Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination [J].
Barouch, DH ;
Santra, S ;
Kuroda, MJ ;
Schmitz, JE ;
Plishka, R ;
Buckler-White, A ;
Gaitan, AE ;
Zin, R ;
Nam, JH ;
Wyatt, LS ;
Lifton, MA ;
Nickerson, CE ;
Moss, B ;
Montefiori, DC ;
Hirsch, VM ;
Letvin, NL .
JOURNAL OF VIROLOGY, 2001, 75 (11) :5151-5158
[5]   Simian immunodeficiency virus containing mutations in N-terminal tyrosine residues and in the PxxP motif in Nef replicates efficiently in rhesus macaques [J].
Carl, S ;
Iafrate, AJ ;
Lang, SM ;
Stolte, N ;
Stahl-Hennig, C ;
Mätz-Rensing, K ;
Fuchs, D ;
Skowronski, J ;
Kirchhoff, F .
JOURNAL OF VIROLOGY, 2000, 74 (09) :4155-4164
[6]   Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].
Chun, TW ;
Stuyver, L ;
Mizell, SB ;
Ehler, LA ;
Mican, JAM ;
Baseler, M ;
Lloyd, AL ;
Nowak, MA ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197
[7]   NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells [J].
Cron, RQ ;
Bartz, SR ;
Clausell, A ;
Bort, SJ ;
Klebanoff, SJ ;
Lewis, DB .
CLINICAL IMMUNOLOGY, 2000, 94 (03) :179-191
[8]   PROTECTIVE EFFECTS OF A LIVE ATTENUATED SIV VACCINE WITH A DELETION IN THE NEF GENE [J].
DANIEL, MD ;
KIRCHHOFF, F ;
CZAJAK, SC ;
SEHGAL, PK ;
DESROSIERS, RC .
SCIENCE, 1992, 258 (5090) :1938-1941
[9]   Viral protein U (Vpu)-mediated enhancement of human immunodeficiency virus type 1 particle release depends on the rate of cellular proliferation [J].
Deora, A ;
Ratner, L .
JOURNAL OF VIROLOGY, 2001, 75 (14) :6714-6718
[10]   Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection [J].
Egan, MA ;
Charini, WA ;
Kuroda, MJ ;
Schmitz, JE ;
Racz, P ;
Tenner-Racz, K ;
Manson, K ;
Wyand, M ;
Lifton, MA ;
Nickerson, CE ;
Fu, TM ;
Shiver, JW ;
Letvin, NL .
JOURNAL OF VIROLOGY, 2000, 74 (16) :7485-7495